In conclusion, PD-L1 TPS prior to neoadjuvant CRT as well as PD-L1 TPS changes showed a statistically significant impact on survival in rectal cancer patients undergoing neoadjuvant CRT, and this was not the case for PD-L1 CPS or PD-L1 IC. Here, CD274 is linked to rectal cancer.